Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report ; volume:12 ; number:1 ; day:20 ; month:3 ; year:2012 ; pages:1-4 ; date:12.2012
BMC ophthalmology ; 12, Heft 1 (20.3.2012), 1-4, 12.2012
- Urheber
-
Yoshino, Hideaki
- Beteiligte Personen und Organisationen
-
Seki, Masaaki
Ueda, Jun
Yoshino, Takaiko
Fukuchi, Takeo
Abe, Haruki
SpringerLink (Online service)
- DOI
-
10.1186/1471-2415-12-3
- URN
-
urn:nbn:de:1111-201604145825
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yoshino, Hideaki
- Seki, Masaaki
- Ueda, Jun
- Yoshino, Takaiko
- Fukuchi, Takeo
- Abe, Haruki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Mydriasert pupillary dilation for cataract surgery: an economic and clinical study
Urokinase-type plasminogen activator receptor in vascular calcification
Plasminogen Activator Release by Oral Contraceptives and Exercise
Influence of delivery on plasminogen activator inhibitor activity
Purification and Some Properties of Tissue Plasminogen Activator
Isolation and Properties of Human Vascular Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Mydriasert pupillary dilation for cataract surgery: an economic and clinical study
Urokinase-type plasminogen activator receptor in vascular calcification
Plasminogen Activator Release by Oral Contraceptives and Exercise
Influence of delivery on plasminogen activator inhibitor activity
Purification and Some Properties of Tissue Plasminogen Activator
Isolation and Properties of Human Vascular Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Mydriasert pupillary dilation for cataract surgery: an economic and clinical study
Urokinase-type plasminogen activator receptor in vascular calcification
Plasminogen Activator Release by Oral Contraceptives and Exercise
Influence of delivery on plasminogen activator inhibitor activity
Purification and Some Properties of Tissue Plasminogen Activator
Isolation and Properties of Human Vascular Plasminogen Activator